Every two years, South Korea adjusts the national health insurance (NHI) prices for existing listed products based on the ...

Madrigal is eying an expansion of MASH blockbuster Rezdiffra’s capabilities via combination with precision siRNA gene ...

Citius Oncology has signed an exclusive distribution agreement with Uniphar to enable access to Lymphir in selected western ...

Outgoing Merck KGaA CEO Belén Garijo is set take the helm at Sanofi, after the French vaccine specialist announced it would not renew existing CEO Paul Hudson’s contract.

MSD has received the US FDA approval for Keytruda and Keytruda Qlex along with paclitaxel, with or without bevacizumab, for ovarian cancer.

The FDA’s refusal to review Moderna's flu vaccine, mRNA-1010, comes within a wider push from the US government to alter ...

Insilico Medicine has announced several AI drug discovery collaborations with CMS across several projects in CNS and ...

The Mexican Government has struck a long-term agreement with Moderna that will see the drugmaker help the country boost its ...

Gilead’s HIV drugs generated $20.8bn in full-year 2025 sales, up 6% from 2024. This was mainly fuelled by the company’s ...

REGENXBIO has received a CRL from the US FDA related to its BLA for RGX-121 to treat MPS II, also called hunter syndrome.

Despite the FDA’s CNPV scheme generating high interest, the process around how voucher awards are prioritised remains unclear ...

Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...